Evidence map›Paper›PMID 25250835›Full record

ArticlePloS one2014

A new mouse allele of glutamate receptor delta 2 with cerebellar atrophy and progressive ataxia.

Yuka Miyoshi, Yoshichika Yoshioka, Kinuko Suzuki, Taisuke Miyazaki, Minako Koura, Kazumasa Saigoh, Naoko Kajimura, Yoko Monobe, Susumu Kusunoki, Junichiro Matsuda and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Purkinje Cell Signaling Deficits in Animal Models of Ataxia.Frontiers in synaptic neuroscience · 2018
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Yuka MiyoshiDepartment of Anatomy and Neurobiology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
Yoshichika YoshiokaBiofunctional Imaging Laboratory, Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan.
Kinuko SuzukiNeuropathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan; Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Taisuke MiyazakiDepartment of Anatomy, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Minako KouraLaboratory of Experimental Animal Models, National Institute of Biomedical Innovation, Ibaraki, Osaka, Japan.
Kazumasa SaigohDepartment of Neurology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
Naoko KajimuraResearch Center for Ultra-High Voltage Electron Microscopy, Osaka University, Ibaraki, Osaka, Japan.
Yoko MonobeSection of Laboratory Equipment, National Institute of Biomedical Innovation, Ibaraki, Osaka, Japan.
Susumu KusunokiDepartment of Neurology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
Junichiro MatsudaLaboratory of Experimental Animal Models, National Institute of Biomedical Innovation, Ibaraki, Osaka, Japan.
Masahiko WatanabeDepartment of Anatomy, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Naoto HayasakaDepartment of Anatomy and Neurobiology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan; Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST), Kawaguchi, Saitama, Japan.
Kindai University · JPNational Institute of Biomedical Innovation, Health and Nutrition · JPHokkaido University · JPOsaka University · JPJapan Science and Technology Agency · JPTokyo Metropolitan Institute of Gerontology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinocerebellar degenerations (SCDs) are a large class of sporadic or hereditary neurodegenerative disorders characterized by progressive motion defects and degenerative changes in the cerebellum and other parts of the CNS. Here we report the identification and establishment from a C57BL/6J mouse colony of a novel mouse line developing spontaneous progressive ataxia, which we refer to as ts3. Frequency of the phenotypic expression was consistent with an autosomal recessive Mendelian trait of inheritance, suggesting that a single gene mutation is responsible for the ataxic phenotype of this line. The onset of ataxia was observed at about three weeks of age, which slowly progressed until the hind limbs became entirely paralyzed in many cases. Micro-MRI study revealed significant cerebellar atrophy in all the ataxic mice, although individual variations were observed. Detailed histological analyses demonstrated significant atrophy of the anterior folia with reduced granule cells (GC) and abnormal morphology of cerebellar Purkinje cells (PC). Study by ultra-high voltage electron microscopy (UHVEM) further indicated aberrant morphology of PC dendrites and their spines, suggesting both morphological and functional abnormalities of the PC in the mutants. Immunohistochemical studies also revealed defects in parallel fiber (PF)-PC synapse formation and abnormal distal extension of climbing fibers (CF). Based on the phenotypic similarities of the ts3 mutant with other known ataxic mutants, we performed immunohistological analyses and found that expression levels of two genes and their products, glutamate receptor delta2 (grid2) and its ligand, cerebellin1 (Cbln1), are significantly reduced or undetectable. Finally, we sequenced the candidate genes and detected a large deletion in the coding region of the grid2 gene. Our present study suggests that ts3 is a new allele of the grid2 gene, which causes similar but different phenotypes as compared to other grid2 mutants.

Indexed as

AnimalsAtaxiaAtrophyCerebellumMice, Inbred C57BLMutationNerve Tissue ProteinsProtein PrecursorsPurkinje CellsReceptors, GlutamateCbln1 protein, mouseglutamate receptor delta 2Nerve Tissue ProteinsProtein PrecursorsReceptors, Glutamate

Identifiers

PMID25250835
PMCPMC4176021
OpenAlexW1997681758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.